What is the global market size of Point Of Care Diagnostics Market?

Point of Care Diagnostics Market size was valued at USD 47.67 Billion in 2022 and is poised to grow from USD 50.54 Billion in 2023 to USD 81.17 Billion by 2031, growing at a CAGR of 6.1 % in the forecast period (2024-2031).

Who are the key vendors in the Point Of Care Diagnostics Market?

The Point Of Care Diagnostics market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. For instance, in December 2018, Anteo Diagnostics (Australia) and Shanghai GeneoDx Biotechnology (China) announced an agreement to market, sell, and distribute Anteo’s range of AnteoBind products in China The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective and customized solutions for students. 'Abbott Laboratories', 'Siemens Healthineers AG ', 'PTS Diagnostics', 'Roche Diagnostics (Switzerland)', 'Danaher Corporation (US)', 'Becton, Dickinson and Company (US)', 'Quidel Corporation (US)', 'BioMérieux SA (France)', 'Sysmex Corporation (Japan)', 'Thermo Fisher Scientific Inc. (US)', 'Johnson & Johnson (US)', 'bioMérieux SA (France)', 'Nova Biomedical (US)', 'Alere Inc. (US)', 'Beckman Coulter, Inc. (US)', 'Hologic, Inc. (US)', 'Cepheid (US)', 'Ortho Clinical Diagnostics (US)', 'Bio-Rad Laboratories, Inc. (US)', 'Trividia Health (US)', 'Chembio Diagnostic Systems, Inc. (US)'

What is the key market trend for Point Of Care Diagnostics Market?

Technological Advancements in Point of Care Diagnostic: Major market participants have increased their focus on the use of new technologies such as artificial intelligence in the production of efficient point of care diagnostics. Lab-on-a-chip platforms wearable technologies and smart-phone interests among other technologies of its kind have led to major achievements in the point of care testing devices. This will pave the way for subsequent transformations as cloud-based Intelligent systems have opened up numerous possibilities for future revolutions. The formation of new diagnostic systems has been influenced by miniaturization in chip technology, microfluidics and innovative biosensors. One of the key drivers of POCT is lab-on-a-chip technology, notably in infectious illness detection. Microbiological culture, enzyme-linked immunosorbent assays (ELISA), and polymerase chain reaction (PCR) can now be employed at the point of care thanks to lab-on-a-chip technology.

Which region accounted for the largest share in Point Of Care Diagnostics Market?

In 2023, the market was dominated by North America with a share of 42.9% and with an increasing number of ageing people and high healthcare costs considered responsible for this domination. Therefore, the market growth is expected due to technological advancements which include miniaturized diagnostic equipment that provides accurate and rapid results, as well as proliferation of Picture Archiving and Communication Systems (PACS) and Electronic Medical Records (EMRs). Nonetheless, companies like BIOMERIEUX, Abbott, Siemens Healthineers AG, BD.

Point Of Care Diagnostics Market Trends

Skyquest Technology's expert advisors have carried out comprehensive research on the point of care diagnostics market to identify the major global and regional market trends and growth opportunities for leading players and new entrants in this market. The analysis is based on in-depth primary and secondary research to understand the major market drivers and restraints shaping the future development and growth of the industry.

Point Of Care Diagnostics Market Dynamics

Drivers

Increasing Technological Advancements to Enhance Usability of Diagnostic Devices

It has become easy to improve the efficiency and accuracy of POCT devices with the help of miniaturization of sensors, development of novel detection methods such as biosensors and microfluidics, and integration of wireless connectivity. Moreover, advancements in materials science and manufacturing techniques allow the production of affordable and efficient POC diagnostics solutions.

High Demand for Convenient Testing leads

Patients and medical providers prefer testing methods that provide quick results. This allows physicians to make immediate decisions and timely interventions. POCT devices fulfil this requirement by offering quick diagnostics at or near the point of care, mitigating the time-consuming procedure of sending samples to centralized labs.

Restraints

High Initial Investment Costs

Medical facilities are facing massive upfront costs while buying POCT from the companies along with additional expense for training, maintaining, and controlling quality. This expense can stop some medical professionals, particularly in limited resource settings, from using POCT technologies.

Time Consuming Professional Training

Intensive training is necessary for medical providers to efficiently operate POCT devices imposing substantial time and resource constraints. This will reduce the speed of the adoption and expansion of POCT services in the medical facilities. Furthermore, the complex nature of some POCT technologies demands specialized skills, increasing the training burden.

Point Of Care Diagnostics Market Report Snapshots

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Point Of Care Diagnostics Market size was valued at USD 50.54 Billion in 2023 and is poised to grow from USD 53.62 Billion in 2024 to USD 86.12 Billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

'Abbott Laboratories (US) ', ' Siemens Healthineers AG (Germany) ', ' Quidel Corporation (US) ', ' F. Hoffman-La Roche Ltd. (Switzerland) ', ' Danaher Corporation (US) ', ' Becton, Dickinson and Company (US) ', ' Chembio Diagnostics (US) ', ' EKF Diagnostics (UK) ', ' Trinity Biotech plc (Ireland) ', ' Instrumentation Laboratory (US) ', ' Nova Biomedical (US) ', ' PTS Diagnostics (US) ', ' Sekisui Diagnostics (US) '

It has become easy to improve the efficiency and accuracy of POCT devices with the help of miniaturization of sensors, development of novel detection methods such as biosensors and microfluidics, and integration of wireless connectivity. Moreover, advancements in materials science and manufacturing techniques allow the production of affordable and efficient POC diagnostics solutions.

The shift towards personalized and targeted therapies presents a significant potential for point-of-care diagnostics. These tools are essential for delivering swift and tailored diagnostic results, enabling healthcare providers to customize treatment strategies based on the unique profiles of individual patients.

North America is dominating the global point of care diagnostics market as it did in the previous revenue period. The rising of geriatric population and the presence of better medical facilities are contributing to the market share. Furthermore, technological advancements like the launch of miniaturized diagnostic equipment providing precise and rapid results are propelling the market growth. The rising market penetration of Picture Archiving and Communication Systems (PACS) and Electronic Medical Records (EMRs) are also increasing the demand of point of care diagnostics market in the region. Moreover, the presence of prominent players like Abbott, BIOMERIEUX, BD, Siemens Healthineers AG, QIAGEN, Quidel Corporation, and Quest Diagnostics is positively influencing market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Point Of Care Diagnostics Market

Report ID: SQMIG35I2098

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE